Unconfirmed Rumors circulate that GlaxoSmithKline plc (GSK) will acquire Human Genome Sciences Inc. (HGSI) at $42.00 a share

December 15, 2010 9:50 AM | 7 seconds read |
Unconfirmed Rumors circulate that GlaxoSmithKline plc (GSK) will acquire Human Genome Sciences Inc. (HGSI) at $42.00 a share.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsRumorsM&ABiotechnologyHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!